CorMedix (CRMD) Misses Q2 EPS by 1c

CorMedix (NASDAQ: CRMD) reported Q2 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• UBS Upgrades Challenger (CGF:AU) (CFIGY) to Buy
• Copart (CPRT) Misses Q4 EPS by 4c